Protein Tyrosine Phosphatase-Like A Regulates Myoblast Proliferation and Differentiation through MyoG and the Cell Cycling Signaling Pathway

REFERENCES

• Adham IM, et al. 2005. The scoliosis (sco) mouse: a new allele of Pax1. Cytogenet. Genome Res. 111:16–26.
   PubMedGoogle Scholar
• Agnati LF, et al. 2006. Allosteric modulation of dopamine D2 receptors by homocysteine. J. Proteome Res. 5:3077–3083.
   PubMed Web of Science ®Google Scholar
• Arnold SR, et al. 2006. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J. Pediatr. Orthop. 26:703–708.
   PubMed Web of Science ®Google Scholar
• Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A. 1998. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:6289–6299.
   PubMed Web of Science ®Google Scholar
• Atherton-Fessler S, et al. 1994. Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol. Biol. Cell 5:989–1001.
   PubMed Web of Science ®Google Scholar
• Barnoud R, et al. 2000. Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am. J. Surg. Pathol. 24:830–836.
   PubMedGoogle Scholar
• Bartkova J, et al. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864–870.
   PubMed Web of Science ®Google Scholar
• Beggs AH, et al. 2010. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc. Natl. Acad. Sci. U. S. A. 107:14697–14702.
   PubMed Web of Science ®Google Scholar
• Berkes CA, Tapscott SJ. 2005. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16:585–595.
   PubMed Web of Science ®Google Scholar
• Braun T, Bober E, Winter B, Rosenthal N, Arnold HH. 1990. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 9:821–831.
   PubMed Web of Science ®Google Scholar
• Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:701–709.
   PubMed Web of Science ®Google Scholar
• Brüning JC, et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
   PubMed Web of Science ®Google Scholar
• Chang J, Knowlton AA, Wasser JS. 2000. Expression of heat shock proteins in turtle and mammal hearts: relationship to anoxia tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:R209–R214.
   PubMedGoogle Scholar
• Chang J, et al. 2003. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 108:407–413.
   PubMed Web of Science ®Google Scholar
• Chen CY, Schwartz RJ. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol. 16:6372–6384.
   PubMedGoogle Scholar
• Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653–6662.
   PubMed Web of Science ®Google Scholar
• Davis RL, Weintraub H, Lassar AB. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987–1000.
   PubMed Web of Science ®Google Scholar
• de Oliveira MV, et al. 2009. SHP-2 regulates myogenesis by coupling to FAK signaling pathway. FEBS Lett. 583:2975–2981.
   PubMedGoogle Scholar
• Du SJ, Gao J, Anyangwe V. 2003. Muscle-specific expression of myogenin in zebrafish embryos is controlled by multiple regulatory elements in the promoter. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 134:123–134.
   PubMedGoogle Scholar
• Edmondson DG, Olson EN. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628–640.
   PubMedGoogle Scholar
• Ewen ME. 2000. Where the cell cycle and histones meet. Genes Dev. 14:2265–2270.
   PubMed Web of Science ®Google Scholar
• Fornaro M, et al. 2006. SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth. J. Cell Biol. 175:87–97.
   PubMedGoogle Scholar
• Goel HL, Dey CS. 2002. Focal adhesion kinase tyrosine phosphorylation is associated with myogenesis and modulated by insulin. Cell Prolif. 35:131–142.
   PubMed Web of Science ®Google Scholar
• Goel HL, Dey CS. 2002. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation. Differentiation 70:257–271.
   PubMedGoogle Scholar
• Hasty P, et al. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501–506.
   PubMed Web of Science ®Google Scholar
• Healy C, Uwanogho D, Sharpe PT. 1999. Regulation and role of Sox9 in cartilage formation. Dev. Dyn. 215:69–78.
   PubMed Web of Science ®Google Scholar
• Hinard V, Belin D, Konig S, Bader CR, Bernheim L. 2008. Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242. Development 135:859–867.
   PubMed Web of Science ®Google Scholar
• Huang C, et al. 2010. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Atherosclerosis 212:123–130.
   PubMedGoogle Scholar
• Johanson M, et al. 1999. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein. Biochem. Biophys. Res. Commun. 265:222–232.
   PubMedGoogle Scholar
• Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271:19146–19151.
   PubMed Web of Science ®Google Scholar
• Konishi H, Okuda A, Ohno Y, Kihara A. 2010. Characterization of HACD1 K64Q mutant found in arrhythmogenic right ventricular dysplasia patients. J. Biochem. 148:617–622.
   PubMedGoogle Scholar
• Kontaridis MI, et al. 2004. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol. Cell. Biol. 24:5340–5352.
   PubMedGoogle Scholar
• Kontaridis MI, Liu X, Zhang L, Bennett AM. 2001. SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis. J. Cell Sci. 114:2187–2198.
   PubMedGoogle Scholar
• Koyama T, et al. 2008. Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway. J. Biol. Chem. 283:24234–24244.
   PubMedGoogle Scholar
• Laporte J, et al. 1997. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum. Mol. Genet. 6:1505–1511.
   PubMedGoogle Scholar
• Laporte J, et al. 1996. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:175–182.
   PubMed Web of Science ®Google Scholar
• Lauper N, et al. 1998. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 17:2637–2643.
   PubMedGoogle Scholar
• Li D, Gonzalez O, Bachinski LL, Roberts R. 2000. Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD. Gene 256:237–243.
   PubMedGoogle Scholar
• Li Q, Lin X, Yang X, Chang J. 2010. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am. J. Physiol. Heart Circ. Physiol. 298:H1340–H1347.
   PubMed Web of Science ®Google Scholar
• Li S, et al. 2005. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. U. S. A. 102:1082–1087.
   PubMedGoogle Scholar
• Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 100:9366–9370.
   PubMed Web of Science ®Google Scholar
• Lu H, et al. 2002. The differentiation of skeletal muscle cells involves a protein-tyrosine phosphatase-alpha-mediated C-Src signaling pathway. J. Biol. Chem. 277:46687–46695.
   PubMedGoogle Scholar
• Lukas J, Bartkova J, Bartek J. 1996. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:6917–6925.
   PubMed Web of Science ®Google Scholar
• Lundberg AS, Weinberg RA. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761.
   PubMed Web of Science ®Google Scholar
• McGowan CH, Russell P. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 12:75–85.
   PubMed Web of Science ®Google Scholar
• Miano JM, et al. 2004. Restricted inactivation of serum response factor to the cardiovascular system. Proc. Natl. Acad. Sci. U. S. A. 101:17132–17137.
   PubMedGoogle Scholar
• Miner JH, Wold B. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. U. S. A. 87:1089–1093.
   PubMedGoogle Scholar
• Nabeshima Y, et al. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532–535.
   PubMed Web of Science ®Google Scholar
• Niu Z, et al. 2005. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J. Biol. Chem. 280:32531–32538.
   PubMed Web of Science ®Google Scholar
• Norbury C, Blow J, Nurse P. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321–3329.
   PubMed Web of Science ®Google Scholar
• Parlakian A, et al. 2004. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol. Cell. Biol. 24:5281–5289.
   PubMed Web of Science ®Google Scholar
• Pelé M, Tiret L, Kessler JL, Blot S, Panthier JJ. 2005. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum. Mol. Genet. 14:1417–1427.
   PubMed Web of Science ®Google Scholar
• Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA. 2009. Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol. Biol. Cell 20:3422–3435.
   PubMed Web of Science ®Google Scholar
• Quach NL, Rando TA. 2006. Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells. Dev. Biol. 293:38–52.
   PubMedGoogle Scholar
• Rhodes SJ, Konieczny SF. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050–2061.
   PubMedGoogle Scholar
• Ridgeway AG, Wilton S, Skerjanc IS. 2000. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:41–46.
   PubMedGoogle Scholar
• Sohal DS, et al. 2001. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89:20–25.
   PubMedGoogle Scholar
• Soulez M, et al. 1996. Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol. Cell. Biol. 16:6065–6074.
   PubMedGoogle Scholar
• Sun L, Chang J, Kirchhoff SR, Knowlton AA. 2000. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am. J. Physiol. Heart Circ. Physiol. 278:H1091–H1097.
   PubMedGoogle Scholar
• Suryawan A, Davis TA. 2003. Protein-tyrosine-phosphatase 1B activation is regulated developmentally in muscle of neonatal pigs. Am. J. Physiol. Endocrinol. Metab. 284:E47–E54.
   PubMedGoogle Scholar
• Uwanogho DA, et al. 1999. Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphatase-like gene. Genomics 62:406–416.
   PubMedGoogle Scholar
• Wang B, Pelletier J, Massaad MJ, Herscovics A, Shore GC. 2004. The yeast split-ubiquitin membrane protein two-hybrid screen identifies BAP31 as a regulator of the turnover of endoplasmic reticulum-associated protein tyrosine phosphatase-like B. Mol. Cell. Biol. 24:2767–2778.
   PubMed Web of Science ®Google Scholar
• Wells NJ, et al. 1999. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J. Cell Sci. 112(Pt. 19):3361–3371.
   PubMedGoogle Scholar
• Wiebel FF, Rennekampff V, Vintersten K, Nordheim A. 2002. Generation of mice carrying conditional knockout alleles for the transcription factor SRF. Genesis 32:124–126.
   PubMedGoogle Scholar
• Wright WE, Sassoon DA, Lin VK. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607–617.
   PubMed Web of Science ®Google Scholar
• Zhang SX, et al. 2005. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J. Biol. Chem. 280:19115–19126.
   PubMed Web of Science ®Google Scholar